Article
SARS-CoV-2 N gene mutations impact detection by clinical molecular diagnostics: reports in two cities in the United States.
Diagnostic microbiology and infectious disease - 1 Nov 2021
Leelawong Mindy, Mitchell Stephanie L, Fowler Randal C, Gonzalez Edimarlyn, Hughes Scott, Griffith Marissa P, Marsh Jane W, Harrison Lee H, Rakeman Jennifer L
Abstract excerpt
Nasal and nasopharyngeal swab specimens tested by the Cepheid Xpert Xpress SARS-CoV-2 were analyzed by whole-genome sequencing based on impaired detection of the N2 target. Each viral genome had at least one mutation in the N gene, which likely arose independently in the New York City and Pittsburgh study sites.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
